Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation

Treatment of recurrent pediatric myelodysplastic syndrome post hematopoietic stem cell transplantation

Key Clinical Message Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4‐year‐old girl experiencing early MDS relapse post‐HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted the...

Full description

Bibliographic Details
Main Authors: Franziska Wachter, Yana Pikman, Jacob Bledsoe, Malika Kapadia, Susanne Baumeister, Jared Rowe, Akiko Shimamura, Andrew E. Place, Susan Prockop, Jennifer Whangbo, Leslie Lehmann, John Horan, Jessica Pollard
Format: Article
Language:English
Published: Wiley 2023-11-01
Series:Clinical Case Reports
Subjects:
disease control
hematopoietic stem cell transplantation
myelodysplastic syndromes
relapse
Online Access:https://doi.org/10.1002/ccr3.8190

Internet

https://doi.org/10.1002/ccr3.8190

Similar Items